Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Rosuvastatin (5mg) tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹99/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Rosumore 5 Tablet containing Rosuvastatin is used for the management of elevated cholesterol and lipid disorders. It helps reduce harmful cholesterol levels and supports cardiovascular health by improving overall lipid profile management.
Rosuvastatin works as an HMG-CoA reductase inhibitor (statin) that helps lower low-density lipoprotein (LDL) cholesterol, total cholesterol, and triglycerides while supporting an increase in beneficial high-density lipoprotein (HDL) cholesterol levels.
The tablet is widely prescribed in cardiology and general medicine practice for patients requiring long-term lipid management and cardiovascular risk reduction, leading to consistent prescription demand.
With the increasing prevalence of dyslipidemia and cardiovascular disorders, this product offers strong business potential for retailers and distributors. Its established clinical efficacy, widespread physician acceptance, and steady market demand make it a reliable product for growth in the cardiac care segment.
Common side effects may include headache, muscle pain, fatigue, and abdominal discomfort. In rare cases, patients may experience liver enzyme elevation, rhabdomyolysis, or hypersensitivity reactions. Periodic monitoring of liver function and creatine kinase levels is advised, especially in patients with predisposing factors for myopathy.
Indicated for the treatment of primary hyperlipidemia or mixed dyslipidemia in adults as an adjunct to diet. It is particularly beneficial for patients requiring additional LDL cholesterol reduction when lifestyle modifications and statin therapy alone are insufficient. The combination is also used in the management of homozygous familial hypercholesterolemia and to lower the risk of cardiovascular events in high-risk patients.
To be used under the supervision of a registered medical practitioner. Not recommended in patients with active liver disease or unexplained persistent elevations in hepatic transaminases. Caution should be exercised in patients with renal impairment or those on other lipid-lowering agents. Avoid use during pregnancy and lactation.
Store at a temperature below 30°C, away from moisture and direct sunlight. Keep out of reach of children.
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin 20mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Rosuvastatin 20 mg + Ezetimibe 10 mg tablet
Composition : Rosuvastatin 10 mg tablet
Composition : Rosuvastatin (20mg) tablet
Composition : Rosuvastatin 10 mg + fenofibrate 160 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Rosuvastatin 5 mg Tablet is a statin-class lipid-lowering medicine used for the management of high cholesterol, mixed dyslipidemia, and prevention of cardiovascular diseases such as heart attack and stroke. It works by reducing cholesterol production in the liver, making it a widely prescribed cardiovascular segment product by cardiologists and physicians. This ensures strong demand in the PCD pharma franchise and chronic care market.
Medical distributors and wholesalers benefit from the high and continuous demand in cholesterol and heart disease management. Rosuvastatin is used as a long-term therapy medicine, which ensures regular repeat prescriptions, stable monthly sales, and consistent movement in both retail and hospital pharmacies.
Yes, Cafoli Lifecare provides PCD pharma franchise opportunities in the cardiovascular and lipid-lowering segment, including Rosuvastatin 5 mg Tablet. We offer monopoly rights, quality-assured manufacturing, and reliable supply support to help franchise partners grow in the chronic cardiac care market.
Wholesalers and stockists benefit from steady prescription-based demand, long-term patient usage, and strong cardiology market acceptance. Since cholesterol management is a lifelong therapy in many patients, it ensures continuous sales flow, low seasonal variation, and stable profitability in pharma distribution.
Medical distributors, stockists, and pharma professionals interested in cardiovascular and lipid management products can contact Cafoli Lifecare for pricing, monopoly franchise rights, and product availability details. We provide complete support including marketing materials, product supply, and territory-based business development assistance.